We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
+48.83%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
AUM
$139M
AUM Growth
+$47.2M
Cap. Flow
+$18.8M
Cap. Flow %
13.57%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
TECX
Tectonic Therapeutic
TECX
+$18.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$62.9M 45.36%
3,931,818
TECX
2
Tectonic Therapeutic
TECX
$578M
$31.2M 22.49%
+1,028,674
New +$18.8M
KYTX icon
3
Kyverna Therapeutics
KYTX
$481M
$22.1M 15.96%
4,523,924
DYN icon
4
Dyne Therapeutics
DYN
$4.24B
$14.6M 10.56%
407,499
ALLO icon
5
Allogene Therapeutics
ALLO
$604M
$5.03M 3.63%
1,798,163
KRON
6
DELISTED
Kronos Bio
KRON
$2.77M 2%
2,765,314

Similar funds

Vida Ventures Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Vida Ventures Advisors held 6 positions worth $139M, up 52% from $91.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vida Ventures Advisors deployed $18.8M of net new capital in Q3 2024, opening 1 new position. Its largest new stake was Tectonic Therapeutic: 1,028,674 shares worth $31.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's largest Q3 2024 buy was Tectonic Therapeutic: 1,028,674 shares worth $31.2M.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $139M portfolio in Q3 2024.
  • Vida Ventures Advisors opened 1 new position and closed 0 in Q3 2024.
  • Vida Ventures Advisors's portfolio value rose 52% quarter-over-quarter to $139M.

Based on Vida Ventures Advisors's 13F filing for Q3 2024, filed 8 Oct 2024.